Squarepoint’s NEVRO CORP. NVRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-28,100
Closed -$2.28M 3658
2021
Q4
$2.28M Hold
28,100
0.01% 1181
2021
Q3
$3.27M Buy
28,100
+23,900
+569% +$3.13M 0.01% 972
2021
Q2
$696K Buy
+4,200
New +$656K ﹤0.01% 1898

Other funds holding NVRO

Squarepoint's NVRO Position: Q2 2025 in Review

Squarepoint sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 82,091 shares — an estimated $479K sold.

Squarepoint first reported a position in NVRO in Q4 2016 and held it in 20 quarters. The position peaked at $5.55M in Q4 2020. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

  • Squarepoint reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
  • Squarepoint sold 82,091 NEVRO CORP. shares in Q2 2025, an estimated $479K.
  • Squarepoint first reported a position in NEVRO CORP. in Q4 2016 and held it in 20 quarters.
  • Squarepoint's NEVRO CORP. position peaked at $5.55M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.